Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Front Aging Neurosci ; 13: 701899, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34489674

RESUMEN

Background: Chlamydia pneumoniae (CPn) is a common community-acquired pneumonia. In the literature, CPn infection is demonstrated to exhibit an association with Alzheimer dementia (AD). We executed the present nationwide, population-based research with the goal of probing the association of CPn infection and antibiotic therapy with AD risk. Methods: We conducted a cohort study using a database extracted from Taiwan's National Health Insurance Research Database (NHIRD). All medical conditions for each enrolled individuals were categorized using the International Classification of Diseases, ninth Revision classifications. Hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between CPn pneumonia-associated hospitalizations and AD were estimated using Fine and Gray's survival analysis and adjusted for comorbidities. The effects of the antibiotics on the HRs for AD in the patients with CPn pneumonia-associated hospitalization were also analyzed. Results: Our analyses included 6,628 individuals, including 1,657 CPn-infected patients, as well as 4,971 controls matched by age, index date, and sex (1:3). In this study, patients hospitalized for CPn pneumonia exhibited a significantly higher AD risk (adjusted HR = 1.599, 95% CI = 1.284-1.971, p < 0.001). We also noted an association of macrolide use (≥15 days) and fluoroquinolone use (≥15 days) with decreased AD risk. Conclusions: We determined CPn pneumonia to be associated with a relatively high AD risk. The result in this study confirmed the findings from previous literatures, by using a large, nationwide, population-based database. Appropriate macrolide and fluoroquinolone treatment may attenuate this risk.

2.
Eur Arch Otorhinolaryngol ; 276(3): 761-765, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30604060

RESUMEN

OBJECTIVE: Montelukast is a selective and orally active leukotriene D4 receptor antagonist often used in treating asthma and allergic rhinitis. Montelukast nasal spray was developed to avoid systemic adverse effects of the drug in vitro. However, the effects of montelukast on human nasal mucosa are not yet fully explored and potential nasal vascular side effects of the drug merit further exploration. First, the effects of montelukast on vasocontractile responses generated by smooth muscles in the vascular structures of human nasal mucosa were investigated directly in vitro. METHODS: This study examined the effects of montelukast on human nasal mucosa in terms of mucosa resting tension, vasoconstriction caused by 10- 6 M methoxamine as a sympathetic mimetic, and electrically induced vasoconstrictions. RESULTS: The results indicated that addition of methoxamine to the incubation medium caused the nasal mucosa to vasocontract in a dose-dependent manner. Addition of montelukast at doses of 10- 5 M or above elicited a significant vasodilation response to 10- 6 M methoxamine-induced vasoconstriction. Montelukast could not inhibit electrical field stimulation-induced spike vasoconstriction. Moreover, increase in concentration of montelukast had minimal effect on basal tension of nasal mucosa. CONCLUSIONS: The study indicated significant vasodilation on human nasal mucosa under high concentrations of montelukast with a probable α-adrenoceptor antagonism. Hence, the nasal activity of α-adrenergic agonist nasal spray for nasal obstruction may be reduced in those using concomitant (oral or local spray) montelukast.


Asunto(s)
Acetatos/farmacología , Antiasmáticos/farmacología , Antagonistas de Leucotrieno/farmacología , Músculo Liso/efectos de los fármacos , Mucosa Nasal/efectos de los fármacos , Quinolinas/farmacología , Ciclopropanos , Estimulación Eléctrica , Humanos , Técnicas In Vitro , Metoxamina/farmacología , Músculo Liso/irrigación sanguínea , Rociadores Nasales , Sulfuros , Vasoconstricción , Vasoconstrictores/farmacología
3.
Eur Arch Otorhinolaryngol ; 276(2): 417-420, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30506184

RESUMEN

OBJECTIVE: Nasal septal abscess is an uncommon condition but it can cause potentially life-threatening intracranial complications and cosmetic nasal deformity. METHODS: We analyzed ten years of cases to determine the optimal diagnostic and therapeutic modalities. A retrospective review of case notes from Tri-Service General Hospital archives was performed. Records of six patients diagnosed with nasal septal abscess, who were treated from September 2007 to August 2017 were retrospectively reviewed. Patients' clinical symptoms, etiology, diagnostic methods, bacteriology, antibiotic and surgical treatment were recorded and analyzed. RESULTS: Out of six patients diagnosed with nasal septal abscess, three were male and three were female. Ages ranged from 19 to 75 years (mean 51 years). The most common symptoms at presentation were nasal pain and nasal obstruction. Typical etiologies were trauma or acute sinusitis, but uncontrolled diabetes mellitus was also an important etiology. In the series of six patients, four of them had positive findings of abscess and in drainage, had the following bacterial cultures: Staphylococcus aureus (two cases), methicillin-resistant S. aureus (one case), and Klebsiella pneumoniae (one case). In addition to antibiotic treatment, all patients underwent surgical drainage and had complete resolution of disease without intracranial complications during at least 1 year of follow-up. However, two out of the six patients developed saddle nose deformity. CONCLUSIONS: This study highlights that: 1. In view of the rapidly increasing number of diabetes mellitus cases, uncontrolled diabetes mellitus is an important etiology of nasal septal abscess. 2. Although S. aureus is the most common pathogen, we must pay attention to methicillin-resistant S. aureus (MRSA) to prevent severe complications and patients who are at increased risk for MRSA colonization should be administrated antibiotics against MRSA initially. 3. Nasal septal abscess should be managed with parenteral broad spectrum antibiotics, appropriate drainage and immediate reconstruction of the destructed septal cartilage with autologous cartilage graft, to prevent serious intracranial complications and cosmetic nasal deformity.


Asunto(s)
Absceso/diagnóstico , Absceso/terapia , Tabique Nasal/lesiones , Tabique Nasal/microbiología , Absceso/etiología , Adulto , Anciano , Antibacterianos/uso terapéutico , Complicaciones de la Diabetes , Drenaje , Femenino , Humanos , Klebsiella pneumoniae/aislamiento & purificación , Masculino , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Persona de Mediana Edad , Obstrucción Nasal/etiología , Deformidades Adquiridas Nasales/etiología , Dolor/etiología , Estudios Retrospectivos , Sinusitis/complicaciones , Staphylococcus aureus/aislamiento & purificación , Adulto Joven
4.
J Am Acad Psychiatry Law ; 45(3): 316-324, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28939729

RESUMEN

We examined the mandatory treatment referral rates before and after Taiwan's Penal Code revision of 2006 and factors associated with the mandatory treatment in Taiwan of criminals who engage in substance abuse. The 3,467 offenders who underwent forensic psychiatric assessments, based on Taiwan's court sentence dataset, included 3,163 offenders with substance-abuse-related crimes, but only 412 (13%) received mandatory treatment. There were no changes in mandatory treatment referral rates before and after the revision. The three main factors that determined whether an offender received mandatory psychiatric treatment were an agreement by the forensic psychiatrist and the presiding judge attesting to the lack of legal responsibility during the commission of the offense, the presence of substance-related psychosis, and location of the court in a rural area.


Asunto(s)
Criminales/psicología , Tratamiento Involuntario , Psicoterapia , Trastornos Relacionados con Sustancias/psicología , Trastornos Relacionados con Sustancias/terapia , Femenino , Humanos , Masculino , Taiwán
5.
Eur Arch Otorhinolaryngol ; 272(10): 2861-5, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25394582

RESUMEN

Sumatriptan (Imigran) is a potent and highly selective 5-HT1 receptor agonist often used in treating acute migraine. Intranasal sumatriptan is well absorbed and is generally effective in relieving headache. However, the effects of Imigran given intratracheally have rarely been well explored. We aimed to verify the effect of Imigran, which acts on the tracheal smooth muscle directly in vitro. We examined the effectiveness of Imigran on isolated rat tracheal smooth muscle by testing: (1) effect on tracheal smooth muscle resting tension; (2) effect on contraction caused by 10(-6) M methacholine as a parasympathetic mimetic; (3) effect of the drugs on electrically induced tracheal smooth muscle contractions. The results indicated that the addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. The addition of Imigran at doses of 10(-5) M or above elicited a significant relaxation response to 10(-6) M methacholine-induced contraction. Imigran could inhibit electrical field stimulation-induced spike contraction. It also had a minimal effect on the basal tension of trachea as the concentration increased. The study indicated high concentrations of Imigran could cause bronchodilation to reduce asthma attacks not only by blocking parasympathetic tone, but also by directly antagonizing the effect of cholinergic receptors.


Asunto(s)
Asma/tratamiento farmacológico , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Sumatriptán/administración & dosificación , Tráquea/efectos de los fármacos , Animales , Asma/fisiopatología , Modelos Animales de Enfermedad , Estimulación Eléctrica , Músculo Liso/fisiopatología , Rociadores Nasales , Ratas , Agonistas del Receptor de Serotonina 5-HT1/administración & dosificación
6.
Gen Hosp Psychiatry ; 33(1): 84.e5-7, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21353143

RESUMEN

We present the case of a woman with paranoid schizophrenia who was receiving oral risperidone. She developed neuroleptic malignant syndrome (NMS) following the addition of depot fluphenazine for the treatment of refractory delusions. NMS subsided and psychotic features were controlled after both antipsychotics were discontinued and the patient was treated instead with olanzapine.


Asunto(s)
Antipsicóticos/efectos adversos , Flufenazina/análogos & derivados , Síndrome Neuroléptico Maligno/etiología , Risperidona/efectos adversos , Adulto , Antipsicóticos/administración & dosificación , Antipsicóticos/uso terapéutico , Deluciones/tratamiento farmacológico , Femenino , Flufenazina/administración & dosificación , Flufenazina/efectos adversos , Flufenazina/uso terapéutico , Humanos , Risperidona/administración & dosificación , Risperidona/uso terapéutico , Esquizofrenia Paranoide/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA